The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled, parallel-group trial-design and rationale

Overview of attention for article published in Respiratory Research, April 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

policy: 1 policy source

twitter: 6 X users

Readers on

mendeley: 85 Mendeley

Summary Policy documents X

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 26,405 followers.

The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled,... http://t.co/t2lUl8cjPw

22 Jun 2013

Reply Repost Favourite

RT @luisotobajas: The TIOSPIR trial is comparing CV safety of tiotropium when given via the HandiHaler and Respimat delivery systems http://t.co/15QtVKzanz"

22 May 2013

Reply Repost Favourite

The TIOSPIR trial is comparing CV safety of tiotropium when given via the HandiHaler and Respimat delivery systems http://t.co/15QtVKzanz"

22 May 2013

Reply Repost Favourite

RT @sanoysalvoblog: The TIOSPIR trial is comparing CV safety of tiotropium when given via the HandiHaler and Respimat delivery systems http://t.co/oZW9Acdi2p

21 May 2013

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.